Merck Animal Health announces $1.3bn acquisition of Elanco’s aqua business

By on    Healthcare Industry News  

Merck Animal Health announces $1.3bn acquisition of Elanco’s aqua business

Merck Animal Health, a division of Merck & Co., Inc., headquartered in Rahway, New Jersey, USA, has announced its definitive agreement to acquire the aquaculture division of Elanco Animal Health Incorporated for $1.3 billion in cash. This strategic acquisition encompasses an innovative array of medicines, vaccines, nutritionals, and supplements tailored for aquatic species, alongside two […]

Bayer completes sale of animal health business to Elanco

By on    Pharma Industry News  

Bayer completes sale of animal health business to Elanco

Bayer has wrapped up its previously announced $7.6 billion sale of its animal health business division to US-based Elanco Animal Health. The transaction, which was announced in August 2019, was closed after meeting the closing conditions, which includes regulatory approvals. Following the closing of the deal, Bayer has been paid $5.17 billion in cash after […]